- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Event 184 results
Webinar
May 12, 2021
Personal Jurisdiction Over Life Science Businesses In Light of Recent Supreme Court Decisions
Webinar
April 29, 2021
Protecting Your CARES Act Provider Relief Funds During Audit and Enforcement: The Time to Act Is Now
Speaking Engagement
April 28, 2021
Geneviève Michaux, Chris Markus to Speak at Q1 Productions’ 3rd Annual Combination Products Regulation Conference
Webinar
Speaking Engagement
March 23, 2021
Kyle Sampson to Speak on 8th Annual Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care Products Virtual Conference
Webinar
March 16, 2021
The New Intensified Scrutiny and Enforcement of FDA-Regulated Clinical Trials
Speaking Engagement
March 8, 2021
Heather Bañuelos to Speak at DIA’s Advertising and Promotion Regulatory Affairs Conference
Webinar
March 4, 2021
Talk im Turm – AI & Life Sciences: Where do we stand in the EU and what to expect in 2021?
Speaking Engagement
March 3, 2021
Preeya Noronha Pinto to Speak on FDLI’s Virtual Introduction to Medical Device Law and Regulation Conference
Webinar
February 23, 2021
FDA Inspections in 2021 for Drug and Device Manufacturers
Speaking Engagement
February 3, 2021
Eric Henry to Speak Virtually on Medical Device Safety Monitoring and Reporting Conference